- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04073043
Telephone Coaching Intervention for Postpartum Depression and Anxiety
A Pilot Randomized Trial of a Telephone Coaching Intervention for Postpartum Depression and Anxiety
Mental health problems affect up to 20% of women at some point during the perinatal period (i.e., from pregnancy to one year postpartum. Perinatal mental health (PMH) problems have been associated with many negative obstetric outcomes, such as higher elective caesarean section, premature delivery, pre-eclampsia, lower fertility rates, and longer postpartum hospital stay.
This research study is a pilot randomized controlled trial (RCT) to assess the feasibility, acceptability, and potential benefits of a low cost sustainable web-based intervention (WBI) with telephone coaching for women with mild to moderate symptomatology of postpartum depression and anxiety.
The intervention contains modules that will help postpartum mothers:
- Learning new information to better understand their condition. This can help mothers feel that they are not alone, and that their experience is not abnormal. It gives a better understanding that can help them feel more confident in their communications with health care professionals and can make it easier to share their experience with family and friends.
- Learning and practicing new skills. This can help mothers feel confident that they can engage in the behaviours that have been shown to be beneficial for mood and to improve stress. This can include learning to plan activities like physical exercise, practice proper sleep hygiene or learning to use a new way of thinking about problems to help you find solutions.
This trial represents a first step to implement a sustainable intervention for PMH problems in order to better serve women's PMH needs and preferences for support. This will help inform the current gap in low cost web-based interventions for PMH.Specific deliverables (in both French and English) include: a manual detailing coaching procedures; reports for decision makers and short summaries for stakeholder groups
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Among women who present with symptoms of depression or anxiety within 5 - 12 weeks of giving birth, the following research questions will be considered:
Feasibility and Acceptability of the two intervention components - WBI and coaching:
a) Among women in the coached and non-coached groups: i) What are participant perceptions of the usability of the WBI with regard to the layout, navigation and functionality at 3 months following randomization? ii) What are the rates of satisfaction with the intervention at 6 months? b) Among women in the coached group: i) What are rates of completion of the planned telephone contacts? ii) What are participant perceptions of the acceptability of the coaching at 6 months? iii) What are coach perceptions of acceptability of coaching intervention?
- Effectiveness: The EPDS is the primary outcome measure for depression and the GAD-7 is the primary outcome measure for anxiety i) Primary outcomes: What is the effect of coaching on the severity of depression and/or anxiety symptoms at the 3 and 6 month follow-up? ii). Secondary outcomes: What is the effect of coaching at 3 and 6 months on maternal functioning, parental stress and at 6 months on use of mental health services, and barriers to use of these services?
Hypothesis: The investigators expect a decrease in scores in the EPDS and GAD-7 in the group with coaching when compared to the group without coaching at 6 months.
The investigators will conduct a pilot single -blind randomized control trial with lay telephone coaching with two groups of women, one assigned to the WBI with coaching and the other to the self-guided WBI. This RCT would consist of the following steps:
- Recruiting a sample of women immediately post-birth(24 hrs) at SMHC and obtaining consent to contact them again within 5 - 12 weeks postpartum
- 5-12 weeks postpartum: Screen women for eligibility for RCT;
- Request informed consent to RCT
- Baseline measures (T0);
- Follow up at 3 months (T1) and
- Follow-up at 6 months (T2). Women who deliver elsewhere in the CIUSSS can be referred to the study at 5-12 weeks postpartum. These women then follow steps 2-6
The participants will be asked to answer online questionnaires at each time point as mentioned above and use web-based resources for information and support after giving birth. The intervention group will receive telephone support from coaches to help answer questions and navigate the website material.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Quebec
-
Montreal, Quebec, Canada, H3T 1M5
- St. Mary's Hospital Centre
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Age 18+ (at birth)
- Ability to speak English or French
- Livebirth
- Access to the internet and email
Inclusion criteria (at step 2):
- Score on either EPDS 10 - 19 or GAD-7 of 10+. Women with a GAD-7 score of 15+ will be referred to the mental health nurse and will be included in the study.
- Baby at home
Exclusion Criteria:
- Women currently undergoing psychological treatment and /or having a history of bipolar disorder or psychosis will be excluded
- Severe symptoms (Score of 20 or more on the EPDS, will be excluded Any anti-depressant and/or psychological treatment will be managed by the participant's own physician and not by the research team.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: SINGLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
EXPERIMENTAL: Intervention Group
The intervention group will have access to the web-based intervention along with telephone coaching.
Participants in the intervention will receive 7 coach calls over a period of 12 weeks.
|
Access to Telephone Coaching for a period of 12 weeks
|
NO_INTERVENTION: Control Group
The control group will have access only to the web-based intervention without telephone support
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Edinburgh Postnatal Depression Scale (EPDS)
Time Frame: Screening, 3 months & 6 months
|
The Edinburgh Postnatal Depression Scale (EPDS) is a 10-item self-report measure, with a four point response scale, and is designed to screen participants for depressive symptoms in the last seven days.
The EPDS includes one question (Item 10) about thoughts of self-harm.
Sum scores for the 10 items are used to generate a total score.
This measure has optimal sensitivity and specificity using a cut-off score of 12.
For the purposes of this study, a cut off score of 10+ is used to identify participants with potentially clinically significant depressive symptoms .
Women who score 20 or over on the EPDS will be excluded and is considered to be in the range of severe symptoms.
A score of 10-19 will be included in the study and is considered to be mild to moderate symptoms.
An increase in these scores in either category would be consdiered as an increase in symptoms of depression
|
Screening, 3 months & 6 months
|
Generalized Anxiety Disorder-7 (GAD-7)
Time Frame: Screening,3 months & 6 months
|
The seven-item, self-report Generalized Anxiety Disorder (GAD-7) questionnaire, designed to screen for and measure the level of anxiety symptoms during the last seven days.
An identified cut point of 10 is used for this study.
Women who have a GAD-7 of greater than 15 will be considered as showing symptoms of anxiety in the severe range.
a score of 10 - 15 will be considered mild to moderate symptoms of anxiety.
|
Screening,3 months & 6 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Questions on usability & acceptability
Time Frame: 3 months
|
All participants will complete a survey at 3 months after randomization to assess usability (layout, navigation, functionality) and acceptability (overall usefulness, usefulness of specific topics, utility of the site for improving mood and engaging in healthy behaviours, credibility and program length/duration).
System usage data will complement users' self-reports and include frequency and duration of user log in, number of modules viewed.
Given that a mean adherence rate of about 50% (defined as number of modules completed) has been observed in e-mental health interventions showing significant changes in outcomes, this cut-off has been selected as an acceptable usage metric.
|
3 months
|
Barkin Index of Maternal Functioning (BIMF)
Time Frame: Baseline, 3 months & 6 months
|
The Barkin Index of Maternal Functioning (BIMF) is designed to measure maternal functioning in new mothers.
It is known for its comprehensibility, patient-centered assessment style, and psychometric profile.
The 20 item BIMF is based on the experiences of women experiencing new motherhood and has a possible range of 0 to 120 with a total score of 120 indicating optimal maternal functioning.
|
Baseline, 3 months & 6 months
|
Parental Stress Questionnaire (PARSS)
Time Frame: Baseline, 3 months & 6 months
|
The Parental Stress Questionnaire (PARSS) is an 18 item questionnaire designed to measure the positive aspects of parenting as well as the negative stressful aspects.
The self-report five point scale helps parents rate how they feel about the relationship with their child by agreeing or disagreeing on various themes of parenting.
The tool is used to assess the change in level of stress and would inform the level of support or services need to improve parenting capacity.
The 8 positive items are reverse scored so that possible scores on the scale can range between 18-90.
Higher scores on the scale indicate greater stress.
|
Baseline, 3 months & 6 months
|
Client Satisfaction Questionnaire (CSQ-8)
Time Frame: 6 months
|
Satisfaction with the intervention will be measured with an 8-item open-ended questions that will ask participants what they liked most about the intervention and what could be improved.
|
6 months
|
Questionnaire on Use of services for mental health problems
Time Frame: Baseline & 6 months
|
This measure uses questions adapted from the Canadian Community Mental Health Questionnaire (CCMHS).
These questions ask about visits to psychiatrists, psychologists, family doctors, nurse, social workers, self-help groups, and other community services for mental health problems since they entered the study.
The questions will identify the percentage of women who have used these services since the time they entered the study.
|
Baseline & 6 months
|
Acceptability of Coaching Questionnaire
Time Frame: 6 months
|
The intervention group will receive an additional questionnaire at 6 months on the usefulness (positive and negative aspects) of having support and guidance from the coach
|
6 months
|
Coach logs and records
Time Frame: 6 months
|
Adherence to the coaching will be tracked in coach logs that record attempted and completed, duration of contacts, topics covered, modules that were recommended and/or used, goals set, and problems that arose.
Contacts will be tape-recorded for fidelity monitoring.
|
6 months
|
Coach exit interview
Time Frame: 6 months
|
At the end of the study, the coach will participate in a semi structured exit interview regarding their experiences, the challenges that arose in delivering this form of support, and how the intervention could be improved.
|
6 months
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Hannah Schwartz, MDCM, McGill University
Study record dates
Study Major Dates
Study Start (ACTUAL)
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ACTUAL)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- SMHC-18-25
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Postpartum Depression
-
University of British ColumbiaCanadian Institutes of Health Research (CIHR); Women's Health Research Institute...CompletedPostpartum Depression | Perinatal Disorder | Postpartum Disorder | Perinatal Depression | Postpartum Anxiety | Postnatal DepressionCanada
-
University of CoimbraEnrolling by invitationPostPartum DepressionPortugal
-
University of MinnesotaNational Institute of Mental Health (NIMH)Completed
-
Sage TherapeuticsCompletedSevere Postpartum DepressionUnited States
-
Women's College HospitalCanadian Institutes of Health Research (CIHR); Michael Garron HospitalCompletedPostpartum Depression | Postpartum Anxiety | Postpartum Blues | Postpartum Mood DisorderCanada
-
Gazi UniversityCompletedPostpartum Depression | Postpartum AdaptationTurkey
-
British Columbia Children's HospitalActive, not recruiting
-
University of RochesterMae Stone Goode FoundationCompletedPostpartum Depression | Postpartum AnxietyUnited States
-
Hacettepe UniversityCompletedQuality of Life | Postpartum Depression | Nursing Caries | Nurse's Role | Postpartum Disorder | Postpartum AnxietyTurkey
Clinical Trials on Telephone Coaching
-
CHU de ReimsCompletedSubjects Aged 75 Years or More Living at HomeFrance
-
Pennington Biomedical Research CenterLouisiana State University Health Care Services DivisionCompletedHypertension | Obesity | Diabetes | OverweightUnited States
-
Brigham and Women's HospitalUniversity of Maryland, Baltimore; National Institute on Aging (NIA)CompletedDepression | Malnutrition | Anxiety | Sedentary Behavior | Loneliness | IsolationUnited States
-
Nantes University HospitalTerminated
-
University of UtahCompletedObesityUnited States
-
University Hospital, BordeauxFondation ApicilCompleted
-
University of British ColumbiaCompleted
-
Sodertalje HospitalKarolinska InstitutetCompletedChildhood Obesity
-
Dana-Farber Cancer InstitutePatty Brisben Foundation For Women's Sexual HealthCompletedOvarian CancerUnited States
-
Seoul National University HospitalChonbuk National University Hospital; Asan Medical Center; Chonnam National University... and other collaboratorsCompletedSolid Tumor | Advanced CancerKorea, Republic of